Leerink Partners Downgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Morgan Stanley Downgrades Globus Medical (GMED) to Equalweight
July 27, 2016 3:02 PM EDTMorgan Stanley downgraded Globus Medical (NYSE: GMED) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $26.43 yesterday.
... MoreUPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to Hold
July 27, 2016 7:17 AM EDT(Updated - July 27, 2016 10:39 AM EDT)
Canaccord Genuity downgraded Globus Medical (NYSE: GMED) from Buy to Hold with a price target of $28.00 (from $30.00). Analyst Kyle Rose expressed concerns that its US business slow to regain momentum.
Rose explained, "We... More
Wells Fargo Upgrades Globus Medical (GMED) to Market Perform
July 27, 2016 7:16 AM EDTWells Fargo upgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $26.43 yesterday.
... MoreGlobus Medical (GMED) Reports In-Line Q2 EPS
July 26, 2016 4:41 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $137.5 million versus the consensus estimate of $141.78 million.
GUIDANCE:
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus... More
